Cargando…

Proposal for subclassification to select patients for hepatectomy with intermediate hepatocellular carcinoma and Child–Pugh A liver function: A double-center study from China

Increasing evidence has shown that hepatectomy provides a longer overall survival (OS) for patients with hepatocellular carcinoma (HCC) in the intermediate stage. Unfortunately, not all patients benefit from liver resection, even if hepatectomy is feasible. This study aimed to propose a subclassific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Wei, Rao, Quan, An, Yongbo, Li, Mengyi, Xu, Gang, Sang, Xinting, Lu, Xin, Zhang, Zhongtao, Mao, Yilei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133538/ https://www.ncbi.nlm.nih.gov/pubmed/30095644 http://dx.doi.org/10.1097/MD.0000000000011800

Ejemplares similares

Evolution and current status of the subclassification of intermediate hepatocellular carcinoma
por: Yi, Peng-Sheng, et al.
Publicado: (2020)

Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
por: Miyata, Tatsunori, et al.
Publicado: (2021)

Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma
por: Xu, Wei, et al.
Publicado: (2018)

Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification
por: Yamamoto, Masateru, et al.
Publicado: (2021)

Modified Child-Pugh grade vs albumin-bilirubin grade for predicting prognosis of hepatocellular carcinoma patients after hepatectomy
por: Huang, Feng, et al.
Publicado: (2020)

Application of acoustic radiation force impulse elastography combined with serum markers in Child-Pugh grading
por: Wei, Linglin, et al.
Publicado: (2020)

Proposal of a T3 Subclassification for Colon Carcinoma
por: Merkel, Susanne, et al.
Publicado: (2022)

Child-Pugh Parameters and Platelet Count as an Alternative to ICG Test for Assessing Liver Function for Major Hepatectomy
por: Au, Kin-Pan, et al.
Publicado: (2017)

Laparoscopic hepatectomy for patients who received enterostomy
por: Jin, Bao, et al.
Publicado: (2019)

A proposal for T1 subclassification in hepatocellular carcinoma: reappraisal of the AJCC 8th edition
por: Lee, Chao-Wei, et al.
Publicado: (2022)

An mALBI-Child–Pugh-based nomogram for predicting post-hepatectomy liver failure grade B–C in patients with huge hepatocellular carcinoma: a multi-institutional study
por: Xu, Ming-Hao, et al.
Publicado: (2022)

Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma
por: Itoh, Shinji, et al.
Publicado: (2022)

Pathobiological and Radiological Approach For Hepatocellular Carcinoma Subclassification
por: Vasuri, Francesco, et al.
Publicado: (2019)

Application of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma related to hepatitis B virus: comparison with traditional one-stage right hepatectomy
por: Zhang, Junwei, et al.
Publicado: (2020)

Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy
por: Hasan, Shaakir, et al.
Publicado: (2017)

Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7
por: Jiang, Jian-Qiang, et al.
Publicado: (2023)

Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma
por: Cheon, Jaekyung, et al.
Publicado: (2023)

Reassessment of different criteria for diagnosing post-hepatectomy liver failure: a single-center study of 1683 hepatectomy
por: Zheng, Yongchang, et al.
Publicado: (2017)

Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
por: Liu, Chen-Hua, et al.
Publicado: (2021)

Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2014)

The Safety and Clinical Outcomes of Chemoembolization in Child-Pugh Class C Patients with Hepatocellular Carcinomas
por: Choi, Tae Won, et al.
Publicado: (2015)

Changes in Inflammatory Markers Predict the Prognosis of Resected Hepatocellular Carcinoma with Child–Pugh A
por: Zhou, Jing, et al.
Publicado: (2022)

Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
por: Costa, Frederico, et al.
Publicado: (2023)

Clinical impact of carbon‐ion radiotherapy on hepatocellular carcinoma with Child‐Pugh B cirrhosis
por: Hiroshima, Yuichi, et al.
Publicado: (2023)

Chinese Ischemic Stroke Subclassification
por: Gao, S., et al.
Publicado: (2011)

The Spectrum of HPV-independent Penile Intraepithelial Neoplasia: A Proposal for Subclassification
por: Regauer, Sigrid, et al.
Publicado: (2023)

Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
por: Zhuang, Lei, et al.
Publicado: (2017)

Rethinking the Barcelona clinic liver cancer guidelines: Intermediate stage and Child-Pugh B patients are suitable for surgery?
por: Romano, Fabrizio, et al.
Publicado: (2021)

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis
por: FEDERICO, ALESSANDRO, et al.
Publicado: (2015)

Response to chemotherapy improves hepatic reserve for patients with hepatocellular carcinoma and Child–Pugh B cirrhosis
por: Terashima, Takeshi, et al.
Publicado: (2016)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients With Child-Pugh B or C Cirrhosis
por: Lee, Peter, et al.
Publicado: (2020)

Lenvatinib in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver function
por: Huynh, Jasmine, et al.
Publicado: (2022)

Type IV Congenital Pouch Colon in Male Children: Anatomical Variations and a Proposed New Subclassification
por: Solanki, Shailesh, et al.
Publicado: (2020)

Child Pugh and ALBI grade: past, present or future?
por: Rimini, Margherita, et al.
Publicado: (2020)

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study
por: Kudo, Masatoshi, et al.
Publicado: (2019)

Perioperative and prognostic implication of albumin‐bilirubin‐TNM score in Child‐Pugh class A hepatocellular carcinoma
por: Sonohara, Fuminori, et al.
Publicado: (2018)

Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial
por: Stemmer, Salomon M., et al.
Publicado: (2021)

Clinical outcomes by Child-Pugh Class in patients with advanced hepatocellular carcinoma in a community oncology setting
por: Aly, Abdalla, et al.
Publicado: (2023)

Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child‐Pugh B cirrhosis
por: Chapin, William J., et al.
Publicado: (2022)

Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis
por: Dong, Zhao-Ru, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r3urvunfvdbehiurtnrgrjvham